Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lip Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05316688
What this trial is testing

A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During Surgery

Who this might be right for
Oral Cavity Squamous Cell CarcinomaStage I Lip and Oral Cavity Cancer AJCC v8Stage II Lip and Oral Cavity Cancer AJCC v8+2 more
University of Washington 8
Testing effectiveness (Phase 2)Study completedNCT00003657
What this trial is testing

High-dose ICE With Amifostine

Who this might be right for
Bladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more
Dana-Farber Cancer Institute 24
Testing effectiveness (Phase 2)Study completedNCT00055913
What this trial is testing

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more
National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00056004
What this trial is testing

Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia

Who this might be right for
Head and Neck CancerLung Cancer
Barbara Ann Karmanos Cancer Institute 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT03854032
What this trial is testing

Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck

Who this might be right for
LipOral Cavity Squamous Cell CarcinomaPharynx+2 more
Thomas Jefferson University 45
Not applicableWithdrawnNCT04985357
What this trial is testing

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

Who this might be right for
Stage III Breast CancerStage IV Breast CancerStage III Lung Cancer+35 more
Travera Inc
Not applicableStudy completedNCT03032250
What this trial is testing

Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer

Who this might be right for
CaregiverMalignant Head and Neck NeoplasmParanasal Sinus Squamous Cell Carcinoma+35 more
Wake Forest University Health Sciences 35
Not applicableStudy completedNCT00310115
What this trial is testing

Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy

Who this might be right for
Bladder CancerCervical CancerEsophageal Cancer+8 more
M.D. Anderson Cancer Center 469
Testing effectiveness (Phase 2)Study completedNCT00458978
What this trial is testing

Cediranib Maleate in Treating Patients With Recurrent or Newly Diagnosed Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+20 more
National Cancer Institute (NCI) 6
Not applicableLooking for participantsNCT00568490
What this trial is testing

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

Who this might be right for
Head and Neck CancerLung CancerLip Cancer+2 more
Stanford University 200
Not applicableWithdrawnNCT00899704
What this trial is testing

Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral Cancer

Who this might be right for
Head and Neck Cancer
Alliance for Clinical Trials in Oncology
Large-scale testing (Phase 3)WithdrawnNCT01545687
What this trial is testing

CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy

Who this might be right for
Head and Neck CancerOral Complications of Radiation TherapyPain+1 more
Alliance for Clinical Trials in Oncology
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Study completedNCT00079053
What this trial is testing

Adjuvant Erlotinib After Completing Chemoradiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
NCIC Clinical Trials Group 19
Large-scale testing (Phase 3)UnknownNCT00720070
What this trial is testing

PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck Cancer

Who this might be right for
Head and Neck Cancer
Warwick Medical School 560
Early research (Phase 1)Study completedNCT00049166
What this trial is testing

Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer

Who this might be right for
Stage II Squamous Cell Carcinoma of the Lip and Oral CavityStage II Squamous Cell Carcinoma of the OropharynxStage III Squamous Cell Carcinoma of the Lip and Oral Cavity+3 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Study completedNCT00052611
What this trial is testing

Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 23
Early research (Phase 1)WithdrawnNCT02915172
What this trial is testing

Lenvatinib and Capecitabine in Patients With Advanced Malignancies

Who this might be right for
Advanced CancerMalignant Neoplasm of BreastMalignant Neoplasms of Bone and Articular Cartilage+11 more
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00002951
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer

Who this might be right for
Esophageal CancerHead and Neck Cancer
University of Chicago 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT03224000
What this trial is testing

Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer

Who this might be right for
Malignant Neoplasms of Lip Oral Cavity and PharynxOropharyngeal Cancer
M.D. Anderson Cancer Center 90
Next Page